Published in Commun Integr Biol on November 01, 2011
Is neurodegenerative disease a long-latency response to early-life genotoxin exposure? Int J Environ Res Public Health (2011) 1.14
Unraveling 50-Year-Old Clues Linking Neurodegeneration and Cancer to Cycad Toxins: Are microRNAs Common Mediators? Front Genet (2012) 0.92
Western Pacific ALS-PDC: a prototypical neurodegenerative disorder linked to DNA damage and aberrant proteogenesis? Front Neurol (2012) 0.83
The olfactory receptor gene superfamily of the mouse. Nat Neurosci (2002) 5.94
Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta (2010) 4.99
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease. Nat Neurosci (2010) 2.99
Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Neurobiol Dis (2002) 1.51
Olfactory impairment in presymptomatic Alzheimer's disease. Ann N Y Acad Sci (2009) 1.49
The role of caspase cleavage of tau in Alzheimer disease neuropathology. J Neuropathol Exp Neurol (2005) 1.44
Slow toxins, biologic markers, and long-latency neurodegenerative disease in the western Pacific region. Neurology (1991) 1.13
Brain inflammation in Alzheimer disease and the therapeutic implications. Curr Pharm Des (1999) 1.10
Conditional activin receptor type 1B (Acvr1b) knockout mice reveal hair loss abnormality. J Invest Dermatol (2010) 1.09
Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease. J Neurol Sci (2011) 1.06
Olfactory dysfunction in three neurodegenerative diseases. Geriatrics (1991) 1.02
The cycad genotoxin MAM modulates brain cellular pathways involved in neurodegenerative disease and cancer in a DNA damage-linked manner. PLoS One (2011) 1.01
Odor identification deficit of the parkinsonism-dementia complex of Guam: equivalence to that of Alzheimer's and idiopathic Parkinson's disease. Neurology (1991) 0.96
Proteomic analysis of the genotoxicant methylazoxymethanol (MAM)-induced changes in the developing cerebellum. J Proteome Res (2006) 0.95
Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex. Acta Neuropathol (2006) 0.92
Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia. Neurology (1998) 0.90
Entire mitogen activated protein kinase (MAPK) pathway is present in preimplantation mouse embryos. Dev Dyn (2004) 0.90
Alzheimer disease: caspases first. Nat Rev Neurol (2010) 0.89
Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes. BMC Med Genomics (2009) 0.88
Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex. J Neuropathol Exp Neurol (1996) 0.86
Biochemical and ultrastructural study of neurofibrillary tangles in amyotrophic lateral sclerosis/parkinsonism-dementia complex in the Kii peninsula of Japan. J Neuropathol Exp Neurol (2003) 0.82
Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol (2009) 1.94
Identification of microsatellites from an extinct moa species using high-throughput (454) sequence data. Biotechniques (2009) 1.59
Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome. Cancer Biol Ther (2011) 1.32
Administration of ricin induces a severe inflammatory response via nonredundant stimulation of ERK, JNK, and P38 MAPK and provides a mouse model of hemolytic uremic syndrome. Am J Pathol (2005) 1.22
Profiling the dead: generating microsatellite data from fossil bones of extinct megafauna--protocols, problems, and prospects. PLoS One (2011) 1.11
c-Jun NH2-terminal kinase promotes apoptosis by down-regulating the transcriptional co-repressor CtBP. J Biol Chem (2006) 1.04
Base excision repair and nucleotide excision repair contribute to the removal of N-methylpurines from active genes. DNA Repair (Amst) (2002) 1.02
O6-methylguanine-DNA methyltransferase Leu84Phe and Ile143Val polymorphisms and risk of colorectal cancer in the Nurses' Health Study and Physicians' Health Study (United States). Cancer Causes Control (2006) 0.94
Probing mechanisms of axonopathy. Part I: Protein targets of 1,2-diacetylbenzene, the neurotoxic metabolite of aromatic solvent 1,2-diethylbenzene. Toxicol Sci (2008) 0.89
Probing mechanisms of axonopathy. Part II: Protein targets of 2,5-hexanedione, the neurotoxic metabolite of the aliphatic solvent n-hexane. Toxicol Sci (2008) 0.89
Upregulation of mitochondrial base-excision repair capability within rat brain after brief ischemia. J Cereb Blood Flow Metab (2003) 0.84
Exploring the feasibility of establishing a disease-specific post-mortem tissue bank in the UK: a case study in ME/CFS. J Clin Pathol (2010) 0.80
Analysis of pesticide exposure and DNA damage in immigrant farmworkers. J Agromedicine (2008) 0.80
New insights into mechanisms of gamma-diketone-induced axonopathy. Neurochem Res (2009) 0.78
The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology (2009) 0.76
Chronic fatigue syndrome or myalgic encephalomyelitis. BMJ (2007) 0.75
Neurological disease on the global agenda. Ann Neurol (2008) 0.75
Neuroanatomical basis of paroxysmal sympathetic hyperactivity: a diffusion tensor imaging analysis. Brain Inj (2015) 0.75
Assessment of Research Interests of First-Year Osteopathic Medical Students. J Am Osteopath Assoc (2016) 0.75
Training mid- to late-career health professionals for clinical work in low-income regions abroad. J Contin Educ Health Prof (2014) 0.75